Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Jayshree Gondane

Jayshree Gondane, BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
How Aligning Science, Marketing, and Sales Creates Sustainable Pharma Growth
Posted in
  • Your POV

How Aligning Science, Marketing, and Sales Creates Sustainable Pharma Growth

Sustainable growth in the pharmaceutical industry requires more than innovative drugs; it demands seamless alignment between … How Aligning Science, Marketing, and Sales Creates Sustainable Pharma GrowthRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Pharma Companies Miss Signals From the Market
Posted in
  • Industry Landscape

Why Pharma Companies Miss Signals From the Market

Pharmaceutical companies invest heavily in research, clinical trials, and marketing, yet many still fail to anticipate … Why Pharma Companies Miss Signals From the MarketRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
How Sales Feedback Can Improve Drug Development Decisions
Posted in
  • Strategy & Execution

How Sales Feedback Can Improve Drug Development Decisions

The success of a new drug depends not only on scientific innovation and regulatory approval but … How Sales Feedback Can Improve Drug Development DecisionsRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Many Life Sciences Products Fail After Approval
Posted in
  • Strategy & Execution

Why Many Life Sciences Products Fail After Approval

Regulatory approval is a major milestone for life sciences products, but it does not guarantee commercial … Why Many Life Sciences Products Fail After ApprovalRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Pharma Launch Teams Start Too Late
Posted in
  • Strategy & Execution

Why Pharma Launch Teams Start Too Late

The timing of pharmaceutical product launches is critical for maximizing market impact, capturing early revenue, and … Why Pharma Launch Teams Start Too LateRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
How Education-Led Marketing Builds Long-Term Brand Equity in Pharma
Posted in
  • Strategy & Execution

How Education-Led Marketing Builds Long-Term Brand Equity in Pharma

In today’s competitive pharmaceutical landscape, building a strong brand goes far beyond traditional promotional campaigns or … How Education-Led Marketing Builds Long-Term Brand Equity in PharmaRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
How Marketing Can Improve Trial Awareness Without Violating Compliance
Posted in
  • Strategy & Execution

How Marketing Can Improve Trial Awareness Without Violating Compliance

Raising awareness for clinical trials is essential to meet enrollment goals, shorten timelines, and ensure diversity … How Marketing Can Improve Trial Awareness Without Violating ComplianceRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Patient Dropout Rates Are Rising in Clinical Research
Posted in
  • Case Studies & Trends

Why Patient Dropout Rates Are Rising in Clinical Research

Patient retention is a critical factor in the success of clinical trials, yet dropout rates have … Why Patient Dropout Rates Are Rising in Clinical ResearchRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
How Poor Investigator Engagement Slows Trial Progress
Posted in
  • Case Studies & Trends

How Poor Investigator Engagement Slows Trial Progress

Clinical trials are complex undertakings that rely heavily on the active participation and engagement of site … How Poor Investigator Engagement Slows Trial ProgressRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Clinical Trial Sites Are Burned Out and What Pharma Can Do
Posted in
  • Case Studies & Trends

Why Clinical Trial Sites Are Burned Out and What Pharma Can Do

Clinical trial sites in the United States are under mounting pressure, with recent surveys showing that … Why Clinical Trial Sites Are Burned Out and What Pharma Can DoRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0

Posts pagination

1 2 … 20 Next

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A